Business Context and Reporting Period
Company: Stoneridge, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 5, 2025
Reporting Period: Third quarter ended September 30, 2025 (results announced via press release referenced in Item 2.02).
Key Financial Metrics and Debt Structure
This filing primarily addresses debt covenant modifications and references Q3 2025 results without providing specific GAAP financial figures (revenue, profit, cash flow) within the text of the 8-K itself. Key debt metrics from the credit agreement amendment include:
- Borrowing Capacity: Reduced from $275,000 to $225,000.
- Interest Coverage Ratio:
- Current minimum of 2.5 extended through March 31, 2026.
- Increases to 3.5 for the quarter ended June 30, 2026, and thereafter.
- If the Control Devices business sale is consummated, the ratio increases to 3.5 as of the last day of the first full quarter ending after the sale.
- Maximum Leverage Ratio:
- 4.5 for the quarter ended September 30, 2025.
- 3.5 for the quarter ended December 31, 2025, and thereafter.
- Permitted Transaction: Sale of the Control Devices business is permitted; proceeds will reduce the credit facility commitment by the lesser of $50,000 or net cash proceeds.
Note: Specific revenue, profit, and cash flow numbers for Q3 2025 are not provided in this filing text; they are contained in the referenced press release (Exhibit 99.1) and presentation (Exhibit 99.2).
Material Changes Versus Prior Period
The primary material change is the execution of Amendment No. 2 to the Fifth Amended and Restated Credit Agreement, effective November 5, 2025. This amendment supersedes previous terms (Amendment No. 1) and introduces:
- A reduction in total borrowing capacity.
- Stricter future interest coverage requirements (rising from 2.5 to 3.5).
- Specific provisions allowing for the sale of the Control Devices business with associated debt reduction mechanics.
Guidance, Outlook, and Risks
Management Commentary and Non-GAAP Measures: The company utilizes various non-GAAP financial measures (e.g., Adjusted EBITDA, Adjusted Free Cash Flow) to facilitate period-to-period comparisons by excluding unusual, non-recurring items.
- 2025 Adjustments: Business realignment costs, strategic review costs, share-based compensation accelerated vesting, and debt compliance adjustments.
- 2024 Adjustments: Business realignment costs, environmental remediation costs, and debt compliance adjustments.
Forward-Looking Statements: The filing incorporates forward-looking statements regarding the company's financial position and expected results, subject to risks and uncertainties detailed in the attached exhibits.
Risks and Contingencies:
- Covenant Compliance: The company must meet the new, higher interest coverage ratios (3.5) starting June 30, 2026, or sooner if the Control Devices sale occurs.
- Asset Sale Execution: The debt structure is contingent on the potential sale of the Control Devices business.
Investor Verification Checklist
- Verify the specific Q3 2025 GAAP revenue, net loss, and cash flow figures in the attached press release (Exhibit 99.1).
- Confirm the current status of the Control Devices business sale and its impact on the $225,000 credit facility commitment.
- Review the reconciliation of GAAP to Non-GAAP measures to understand the magnitude of "business realignment" and "strategic review" costs excluded from adjusted metrics.
- Assess the company's ability to meet the increased interest coverage ratio of 3.5 by June 30, 2026.
- Examine the full text of Amendment No. 2 (Exhibit 10.1) for any additional restrictive covenants not summarized in the 8-K.